Boundless Bio, Inc. (BOLD) revealed Loss for its first quarter that increased from last year
The company's bottom line totaled -$15.430 million, or -$12.27 per share. This compares with -$11.719 million, or -$9.91 per share, in last year's first quarter.
Boundless Bio, Inc. earnings at a glance (GAAP) :
-Earnings (Q1): -$15.430 Mln. vs. -$11.719 Mln. last year.
-EPS (Q1): -$12.27 vs. -$9.91 last year.
For comments and feedback contact: editorial@rttnews.com